MEDIROM Healthcare Technologies Income Statement Analysis

Revenue, earnings, and profit margins in billions JPY

Scroll to see more
MEDIROM Healthcare Technologies Inc. income statement - Annual data in billions JPY
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue8.306.836.955.413.34
Cost of Revenue6.055.265.053.992.91
Gross Profit2.251.571.901.420.43
Operating Expenses
Research & Development0.000.000.000.000.01
Selling, General & Administrative2.241.961.811.811.07
Operating Expenses2.261.941.811.810.96
Operating Income-0.02-0.370.10-0.40-0.53
Other Income/Expense
Interest Income0.000.000.010.000.00
Interest Expense0.050.04-0.01-0.010.01
Other Income/Expense0.070.430.070.05-0.09
Income
Income Before Tax0.050.020.18-0.41-0.63
Income Tax Expense-0.09-0.090.030.58-0.09
Net Income0.150.120.15-0.99-0.54
Net Income - Continuous Operations0.150.120.15-0.990.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA0.390.310.28-0.27-0.55
EBIT0.100.060.10-0.40-0.61
Depreciation & Amortization0.290.250.180.130.03
Earnings Per Share
Basic EPS29.0024.0031.00-203.00-134.00
Diluted EPS29.0022.0027.00-203.00-134.00
Basic Shares Outstanding0.010.000.000.000.00
Diluted Shares Outstanding0.010.010.010.000.00